Neurocrine Bioscience buy Piper Sandler
Start price
31.07.26
/
50%
€146.20
Target price
31.07.27
€182.45
Performance (%)
-11.22%
Price
09:56
€129.80
Summary
This prediction is currently active. The price of Neurocrine Bioscience has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.22%. This prediction currently runs until 31.07.27. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | 0.076% |
| iShares Core DAX® | -1.586% |
| iShares Nasdaq 100 | -4.148% |
| iShares Nikkei 225® | -6.302% |
| iShares S&P 500 | -3.225% |
Comments by Piper_Sandler for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its price target raised by Piper Sandler from $207.00 to $210.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Piper_Sandler for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.15
06.05.26
06.05.26
€176.61
06.05.27
06.05.27
5.40%
09:56
09:56
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.85
29.10.25
29.10.25
€153.67
29.10.26
29.10.26
10.14%
09:56
09:56
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€115.25
31.07.25
31.07.25
€153.09
31.07.26
31.07.26
24.90%
01.08.26
01.08.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.90
06.05.25
06.05.25
€136.35
06.05.26
06.05.26
17.00%
07.05.26
07.05.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€130.60
23.12.24
23.12.24
€153.97
23.12.25
23.12.25
-6.36%
24.12.25
24.12.25

